Global Core Clinical Molecular Diagnostics Market (2023 Edition): Analysis By Technology (ISH, PCR, Sequencing, Others), By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Others), By Region, By Country: Market Insights and Forecast (2019-2029)

Executive Summary

Azoth Analytics has released a research report titled oGlobal Core Clinical Molecular Diagnostics Market (2023 Edition)o which provides a complete analysis of the Global Core Clinical Molecular Diagnostics industry in terms of market segmentation By Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Others) and By Application (Infectious Disease and Blood Screening, Genetic Testing, Cancer Screening, Other Applications) for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

The research report covers a detailed analysis of the regions (Americas, Europe, APAC, Middle East Africa) and 11 countries (United States, Canada, United Kingdom, Germany, Italy, France, Spain, China, India, Japan, Australia). Additionally, the research report presents data including market size, yearly growth and potential analysis, the competitive study of market players, investment opportunities and demand forecast. The research study also assesses market growth indicators, restraints, supply and demand risk, and other important statistics, as well as a full assessment of current and future market trends that are relevant to the market's evolution.

During the forecast period, 2024-2029, the Global Core Clinical Molecular Diagnostics market is expected to grow at a CAGR of 10.7%. The Global Core Clinical Molecular Diagnostics Market is expected to generate USD 11.04 billion by the end of 2029, up from USD 4.9 Billion in 2022.

Clinical Molecular diagnostics is a rapidly expanding market that encompasses a wide range of applications, including infectious illnesses, cancer, hematopathology, clinical chemistry, and clinical genetics. The increasing prevalence of chronic diseases coupled with the growing demand for advanced diagnostic solutions for early disease detection are driving the market growth.

Additionally, the increasing awareness of personalized treatment and direct-to-consumer genetic testing is also supporting the market growth.

Moreover, the rising global prevalence of infectious diseases has significantly contributed to the demand for clinical molecular diagnostics solutions, wherein polymerase chain reaction (PCR) testing has emerged as the primary method for detecting COVID-19. The application of polymerase chain reaction (PCR) testing has played a significant role in enhancing the field of molecular diagnostics for infectious diseases, specifically in nucleic acid-based methodologies. As a result, this particular segment has emerged as one of the most prominent segments within the core clinical molecular diagnostics market.

Scope of the Report:

• The report analyses the Core Clinical Molecular Diagnostics Market by Value (USD Billion).

• The report presents the analysis of Core Clinical Molecular Diagnostics Market for the historical period of 2019-2022, the estimated year 2023 and the forecast period of 2024-2029.

• The report analyses the Core Clinical Molecular Diagnostics Market by Application (Infectious disease and blood screening, Genetic testing, Cancer Screening Other Applications).

• The report analyses the Core Clinical Molecular Diagnostics Market by Technology (In situ hybridization, Polymerase Chain Reaction, Sequencing, Other Technologies).

• The key insights of the report have been presented through the frameworks of SWOT and Porter's Five Forces Analysis. Also, the attractiveness of the market has been presented by Region, by Application & by Technologies.

• Also, the major opportunities, trends, drivers, and challenges of the industry have been analyzed in the report.

• The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Merck Group (SigmaAldrich Co., LLC), F. Hoffmann-La Roche AG, Agilent technologies, PerkinElmer Inc., Abbott Laboratories, QIAGEN, Thermo Fisher Scientific, Becton, Dickinson and Company, Hologic, Inc., Danaher Corporation.

1. Market Background

1.1 Scope and Product Outlook

1.2 Executive Summary

1.3 Research Methodology



2. Strategic Recommendations

2.1 Integration of AI and Data Analytics to deliver highly accurate and rapid results

2.2 Partnerships with Academic Institutes



3. Global Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

3.1 Age-standardised cancer incidence rate, 2020*

3.2 SARS-Cov-2 Tests: Volumes 2020

3.3 Molecular diagnostics undergoing Clinical trials

3.4 Global Core Clinical Molecular Diagnostics Market: Dashboard

3.5 Global Core Clinical Molecular Diagnostics Market: Market Value Assessment, 2019-2029 (USD Billion)

3.6 Impact of COVID-19 on the Global Core Clinical Molecular Diagnostics Market

3.7 Global Core Clinical Molecular Diagnostics Market Segmentation: By Application

3.7.1 Global Core Clinical Molecular Diagnostics Market, By Application Overview

3.7.2 Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.3 Global Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.4 Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

3.7.5 Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

3.8 Global Core Clinical Molecular Diagnostics Market Segmentation: By Technology

3.8.1 Global Core Clinical Molecular Diagnostics Market, By Technology Overview

3.8.2 Global Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.3 Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.4 Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

3.8.5 Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)



4. Global Core Clinical Molecular Diagnostics Market, Region Analysis

4.1 Regional Coverage of the Study



5. Americas Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

5.1 Americas Core Clinical Molecular Diagnostics Market: Snapshot

5.2 Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.3 Americas Core Clinical Molecular Diagnostics Market: Key Factors

5.4 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Application

5.4.1 Americas Core Clinical Molecular Diagnostics Market, By Application Overview

5.4.2 Americas Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.3 Americas Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.4 Americas Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

5.4.5 Americas Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

5.5 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Technology

5.5.1 Americas Core Clinical Molecular Diagnostics Market, By Technology Overview

5.5.2 Americas Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.3 Americas Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.4 Americas Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

5.5.5 Americas Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

5.6 Americas Core Clinical Molecular Diagnostics Market Segmentation: By Country

5.6.1 United States Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.1.1 United States Core Clinical Molecular Diagnostics Market, By Application

5.6.1.2 United States Core Clinical Molecular Diagnostics Market, By Technology

5.6.2 Canada Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.2.1 Canada Core Clinical Molecular Diagnostics Market, By Application

5.6.2.2 Canada Core Clinical Molecular Diagnostics Market, By Technology

5.6.3 Rest of Americas Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

5.6.3.1 Rest of Americas Core Clinical Molecular Diagnostics Market, By Application

5.6.3.2 Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology



6. Europe Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

6.1 Europe Core Clinical Molecular Diagnostics Market: Snapshot

6.2 Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.3 Europe Core Clinical Molecular Diagnostics Market: Key Factors

6.4 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Application

6.4.1 Europe Core Clinical Molecular Diagnostics Market, By Application Overview

6.4.2 Europe Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.3 Europe Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.4 Europe Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

6.4.5 Europe Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

6.5 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Technology

6.5.1 Europe Core Clinical Molecular Diagnostics Market, By Technology Overview

6.5.2 Europe Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.3 Europe Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.4 Europe Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

6.5.5 Europe Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

6.6 Europe Core Clinical Molecular Diagnostics Market Segmentation: By Country

6.6.1 France Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.1.1 France Core Clinical Molecular Diagnostics Market, By Application

6.6.1.2 France Core Clinical Molecular Diagnostics Market, By Technology

6.6.2 United Kingdom Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.2.1 United Kingdom Core Clinical Molecular Diagnostics Market, By Application

6.6.2.2 United Kingdom Core Clinical Molecular Diagnostics Market, By Technology

6.6.2 Italy Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.2.1 Italy Core Clinical Molecular Diagnostics Market, By Application

6.6.2.2 Italy Core Clinical Molecular Diagnostics Market, By Technology

6.6.3 Spain Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.3.1 Spain Core Clinical Molecular Diagnostics Market, By Application

6.6.3.2 Spain Core Clinical Molecular Diagnostics Market, By Technology

6.6.4 Germany Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.4.1 Germany Core Clinical Molecular Diagnostics Market, By Application

6.6.4.2 Germany Core Clinical Molecular Diagnostics Market, By Technology

6.6.5 Rest of Europe Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

6.6.5.1 Rest of Europe Core Clinical Molecular Diagnostics Market, By Application

6.6.5.2 Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology



7. Asia-Pacific Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

7.1 Asia-Pacific Core Clinical Molecular Diagnostics Market: Snapshot

7.2 Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.3 Asia-Pacific Core Clinical Molecular Diagnostics Market: Key Factors

7.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Application

7.4.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application Overview

7.4.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

7.4.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

7.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Technology

7.5.1 Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology Overview

7.5.2 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.3 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.4 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

7.5.5 Asia-Pacific Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

7.6 Asia-Pacific Core Clinical Molecular Diagnostics Market Segmentation: By Country

7.6.1 China Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.1.1 China Core Clinical Molecular Diagnostics Market, By Application

7.6.1.2 China Core Clinical Molecular Diagnostics Market, By Technology

7.6.2 Japan Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.2.1 Japan Core Clinical Molecular Diagnostics Market, By Application

7.6.2.2 Japan Core Clinical Molecular Diagnostics Market, By Technology

7.6.3 India Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.3.1 India Core Clinical Molecular Diagnostics Market, By Application

7.6.3.2 India Core Clinical Molecular Diagnostics Market, By Technology

7.6.4 Australia Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.4.1 Australia Core Clinical Molecular Diagnostics Market, By Application

7.6.4.2 Australia Core Clinical Molecular Diagnostics Market, By Technology

7.6.5 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

7.6.5.1 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Application

7.6.5.2 Rest of Asia-Pacific Core Clinical Molecular Diagnostics Market, By Technology



8. Middle-East & Africa Core Clinical Molecular Diagnostics Market: Historic and Forecast (2019-2029)

8.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Snapshot

8.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Market Size and CAGR, 2019-2029 (USD Billion & CAGR)

8.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market: Key Factors

8.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Application

8.4.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Application Overview

8.4.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Genetic Testing, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

8.4.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Segmentation: By Technology

8.5.1 Middle-East & Africa Core Clinical Molecular Diagnostics Market, By Technology Overview

8.5.2 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By In situ Hybridisation, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.3 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.4 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

8.5.5 Middle-East & Africa Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)



9. Market Dynamics

9.1 Impact Assessment of Market Dynamics on Global Core Clinical Molecular Diagnostics Market

9.2 Drivers

9.3 Restraints

9.4 Trends



10. Porter's Five Forces Analysis

10.1 Porter's Five Forces Model



11. Competitive Positioning

11.1 Companies' Product Positioning

11.2 Market Position Matrix

11.3 Market Share Analysis of Core Clinical Molecular Diagnostics Market

11.4 Company Profiles

11.4.1 Merck Group (SigmaAldrich Co., LLC)

11.4.2 F. Hoffmann-La Roche AG

11.4.3 Agilent technologies

11.4.4 PerkinElmer Inc.

11.4.5 Abbott Laboratories

11.4.6 QIAGEN

11.4.7 Thermo Fisher Scientific

11.4.8 Becton, Dickinson and Company

11.4.9 Hologic, Inc.

11.4.10 Danaher Corporation

List of Figures

Figure 1: Age-standardised cancer incidence rate, 2020*

Figure 2: Global Core Clinical Molecular Diagnostics Market Size, By Value, 2019-2022 (USD Billion)

Figure 3: Global Core Clinical Molecular Diagnostics Market Size, By Value, 2023-2029 (USD Billion)

Figure 4: Global Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)

Figure 5: Global Core Clinical Molecular Diagnostics Market Size, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 6: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Infectious disease and blood screening, 2019-2029 (USD Billion)

Figure 7: Global Core Clinical Molecular Diagnostics Market Size, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 8: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Genetic testing, 2019-2029 (USD Billion)

Figure 9: Global Core Clinical Molecular Diagnostics Market Size, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 10: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Cancer Screening, 2019-2029 (USD Billion)

Figure 11: Global Core Clinical Molecular Diagnostics Market Size, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 12: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Other Applications, 2019-2029 (USD Billion)

Figure 13: Global Core Clinical Molecular Diagnostics Market Size, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 14: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By In situ hybridization, 2019-2029 (USD Billion)

Figure 15: Global Core Clinical Molecular Diagnostics Market Size, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 16: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Polymerase Chain Reaction, 2019-2029 (USD Billion)

Figure 17: Global Core Clinical Molecular Diagnostics Market Size, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 18: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Sequencing, 2019-2029 (USD Billion)

Figure 19: Global Core Clinical Molecular Diagnostics Market Size, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 20: Global Core Clinical Molecular Diagnostics Market Absolute Opportunity, By Others, 2019-2029 (USD Billion)

Figure 21: Americas Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)

Figure 22: Americas Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)

Figure 23: Americas Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 24: Americas Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 25: Americas Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 26: Americas Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 27: Americas Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 28: Americas Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 29: Americas Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 30: Americas Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 31: United States Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 32: United States Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 33: United States Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 34: United States Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 35: Canada Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 36: Canada Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 37: Canada Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 38: Canada Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 39: Rest of Americas Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 40: Rest of Americas Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 41: Rest of Americas Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 42: Rest of Americas Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 43: Europe Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)

Figure 44: Europe Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)

Figure 45: Europe Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 46: Europe Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 47: Europe Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 48: Europe Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 49: Europe Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 50: Europe Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 51: Europe Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 52: Europe Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 53: France Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 54: France Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 55: France Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 56: France Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 57: United Kingdom Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 58: United Kingdom Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 59: United Kingdom Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 60: United Kingdom Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 61: Italy Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 62: Italy Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 63: Italy Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 64: Italy Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 65: Spain Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 66: Spain Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 67: Spain Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 68: Spain Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 69: Germany Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 70: Germany Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 71: Germany Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 72: Germany Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 73: Rest of Europe Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 74: Rest of Europe Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 75: Rest of Europe Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 76: Rest of Europe Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 77: Asia Pacific Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)

Figure 78: Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)

Figure 79: Asia Pacific Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 80: Asia Pacific Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 81: Asia Pacific Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 82: Asia Pacific Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 83: Asia Pacific Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 84: Asia Pacific Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 85: Asia Pacific Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 86: Asia Pacific Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 87: China Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 88: China Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 89: China Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 90: China Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 91: Japan Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 92: Japan Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 93: Japan Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 94: Japan Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 95: India Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 96: India Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 97: India Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 98: India Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 99: Australia Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 100: Australia Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 101: Australia Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 102: Australia Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 103: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Value, 2019-2029 (USD Billion & CAGR)

Figure 104: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Value, By Application, 2022 (USD Billion)

Figure 105: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Application, By Value, 2022 (%)

Figure 106: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market Share, By Technology, 2022 (%)

Figure 107: Middle East and Africa Core Clinical Molecular Diagnostics Market Size, By Value, 2019H-2029F (USD Billion)

Figure 108: Middle East and Africa Core Clinical Molecular Diagnostics Market Share, By Application, 2022 (%)

Figure 109: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Infectious disease and blood screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 110: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Genetic testing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 111: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Cancer Screening, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 112: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Other Applications, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 113: Middle East and Africa Core Clinical Molecular Diagnostics Market, By In situ hybridization, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 114: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Polymerase Chain Reaction, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 115: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Sequencing, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 116: Middle East and Africa Core Clinical Molecular Diagnostics Market, By Others, By Value, 2019H-2029F (USD Billion & CAGR)

Figure 117: Global Impact of Drivers and Restraints

Figure 118: Market Share of Prominent Companies of Core Clinical Molecular diagnostics market, 2022 (%)

Figure 119: Merck Group Revenues, 2020-2022 (USD Million)

Figure 120: Merck Group Revenues, By Geographic Segments, 2022 (%)

Figure 121: Merck Group Revenue , By Business Segments, 2022 (%)

Figure 122: Roche Revenues, 2020-2022 (USD Million)

Figure 123: Roche Revenue , By Business Segment, 2022 (%)

Figure 124: Agilent technologies Revenues, 2020-2022 (USD Million)

Figure 125: Agilent technologies Revenue , By Geographic Segment, 2022 (%)

Figure 126: Agilent technologies Revenue , By Business Segment, 2022 (%)

Figure 127: Abbott Laboratories Revenues, 2020-2022 (USD Million)

Figure 128: Abbott Laboratories Revenues, By Geographic Segments, 2022 (%)

Figure 129: Abbott Laboratories Revenue , By Business Segments, 2022 (%)

Figure 130: Qiagen Revenues, 2020-2022 (USD Million)

Figure 131: Qiagen Revenue , By Customer class , 2022 (%)

Figure 132: Qiagen Revenue , By Geographical Segments, 2022 (%)

Figure 133: Thermo Fisher Revenues, 2020-2022 (USD Million)

Figure 134: Thermo Fisher Revenue , By Geographic segment, 2022 (%)

Figure 135: Thermo Fisher Revenue , By Business Segments, 2022 (%)

Figure 136: Becton, Dickinson and Company Revenues, 2020-2022 (USD Million)

Figure 137: Becton, Dickinson and Company Revenue , By Geographic segment, 2022 (%)

Figure 138: Becton, Dickinson and Company Revenue , By Business Segments, 2022 (%)

Figure 139: Hologic Revenues, 2020-2022 (USD Million)

Figure 140: Hologic Revenue , By Business Segment, 2022 (%)

Figure 141: Hologic Revenue , By Geographical Segments, 2022 (%)

Figure 142: Danaher Revenues, 2020-2022 (USD Million)

Figure 143: Danaher Revenue , By Business Segment, 2022 (%)

Figure 144: Danaher Revenues, By Geographical Segments, 2022 (%)



List of Tables

Table A1: SARS-Cov-2 Tests: Volumes 2020

Table A2: Molecular diagnostics undergoing Clinical trials

Table A3: United States Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A4: United States Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A5: United States Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A6: United States Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A7: Canada Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A8: Canada Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A9: Canada Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A10: Canada Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A11: Rest of Americas Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A12: Rest of Americas Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A13: Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A14: Rest of Americas Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A15: France Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A16: France Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A17: France Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A18: France Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A19: United Kingdom Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A20: United Kingdom Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A21: United Kingdom Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A22: United Kingdom Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A23: Italy Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A24: Italy Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A25: Italy Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A26: Italy Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A27: Spain Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A28: Spain Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A29: Spain Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A30: Spain Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A31: Germany Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A32: Germany Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A33: Germany Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A34: Germany Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A35: Rest of Europe Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A36: Rest of Europe Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A37: Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A38: Rest of Europe Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A39: China Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A40: China Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A41: China Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A42: China Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A43: Japan Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A44: Japan Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A45: Japan Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A46: Japan Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A47: India Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A48: India Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A49: India Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A50: India Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A51: Australia Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A52: Australia Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A53: Australia Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A54: Australia Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A55: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Application, By Value, 2019-2022 (USD Billion)

Table A56: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Application, By Value, 2023-2029 (USD Billion)

Table A57: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2019-2022 (USD Billion)

Table A58: Rest of Asia Pacific Core Clinical Molecular Diagnostics Market, By Technology, By Value, 2023-2029 (USD Billion)

Table A59: Merck Group. Key Financials, 2020-2022

Table A60: Roche Key Financials, 2020-2022

Table A61: Agilent technologies Key Financials, 2020-2022

Table A62: Abbott Laboratories Key Financials, 2020-2022

Table A63: Qiagen Company Financials, 2020-2022

Table A64: Key Company Financials, 2020-2022

Table A65: Becton, Dickinson and Company Key Company Financials, 2020-2022

Table A66: Hologic Company Financials, 2020-2022

Table A67: Danaher Company Financials, 2020-2022

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: Azoth Analytics

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support